FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313308107> ?p ?o ?g. }

• W4313308107 endingPage "e0279333" @default.
• W4313308107 startingPage "e0279333" @default.
• W4313308107 abstract "Background The long-term cardiovascular (CV) outcomes of COVID-19 have not been fully explored. Methods This was an international, multicenter, retrospective cohort study conducted between February and December 2020. Consecutive patients ≥18 years who underwent a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for SARS-CoV2 were included. Patients were classified into two cohorts depending on the nasopharyngeal swab result and clinical status: confirmed COVID-19 (positive RT-PCR) and control (without suggestive symptoms and negative RT-PCR). Data were obtained from electronic records, and clinical follow-up was performed at 1-year. The primary outcome was CV death at 1-year. Secondary outcomes included arterial thrombotic events (ATE), venous thromboembolism (VTE), and serious cardiac arrhythmias. An independent clinical event committee adjudicated events. A Cox proportional hazards model adjusted for all baseline characteristics was used for comparing outcomes between groups. A prespecified landmark analysis was performed to assess events during the post-acute phase (31–365 days). Results A total of 4,427 patients were included: 3,578 (80.8%) in the COVID-19 and 849 (19.2%) control cohorts. At one year, there were no significant differences in the primary endpoint of CV death between the COVID-19 and control cohorts (1.4% vs. 0.8%; HR adj 1.28 [0.56–2.91]; p = 0.555), but there was a higher risk of all-cause death (17.8% vs. 4.0%; HR adj 2.82 [1.99–4.0]; p = 0.001). COVID-19 cohort had higher rates of ATE (2.5% vs. 0.8%, HR adj 2.26 [1.02–4.99]; p = 0.044), VTE (3.7% vs. 0.4%, HR adj 9.33 [2.93–29.70]; p = 0.001), and serious cardiac arrhythmias (2.5% vs. 0.6%, HR adj 3.37 [1.35–8.46]; p = 0.010). During the post-acute phase, there were no significant differences in CV death (0.6% vs. 0.7%; HR adj 0.67 [0.25–1.80]; p = 0.425), but there was a higher risk of deep vein thrombosis (0.6% vs. 0.0%; p = 0.028). Re-hospitalization rate was lower in the COVID-19 cohort compared to the control cohort (13.9% vs. 20.6%; p = 0.001). Conclusions At 1-year, patients with COVID-19 experienced an increased risk of all-cause death and adverse CV events, including ATE, VTE, and serious cardiac arrhythmias, but not CV death. Study registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT04359927 ." @default.
• W4313308107 created "2023-01-06" @default.
• W4313308107 creator A5002630544 @default.
• W4313308107 creator A5003926280 @default.
• W4313308107 creator A5009775466 @default.
• W4313308107 creator A5011188783 @default.
• W4313308107 creator A5012837780 @default.
• W4313308107 creator A5016245888 @default.
• W4313308107 creator A5023337969 @default.
• W4313308107 creator A5033100094 @default.
• W4313308107 creator A5040418600 @default.
• W4313308107 creator A5043877348 @default.
• W4313308107 creator A5044111360 @default.
• W4313308107 creator A5045809081 @default.
• W4313308107 creator A5046413590 @default.
• W4313308107 creator A5046485954 @default.
• W4313308107 creator A5058854673 @default.
• W4313308107 creator A5059280833 @default.
• W4313308107 creator A5073613740 @default.
• W4313308107 creator A5075033637 @default.
• W4313308107 creator A5078376667 @default.
• W4313308107 creator A5079151837 @default.
• W4313308107 creator A5079240490 @default.
• W4313308107 creator A5081547954 @default.
• W4313308107 creator A5081887838 @default.
• W4313308107 creator A5089766701 @default.
• W4313308107 date "2022-12-30" @default.
• W4313308107 modified "2023-10-17" @default.
• W4313308107 title "One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry" @default.
• W4313308107 cites W1920766392 @default.
• W4313308107 cites W2033597783 @default.
• W4313308107 cites W2122779695 @default.
• W4313308107 cites W2154692607 @default.
• W4313308107 cites W2808265769 @default.
• W4313308107 cites W3008867523 @default.
• W4313308107 cites W3010848803 @default.
• W4313308107 cites W3012747666 @default.
• W4313308107 cites W3013231340 @default.
• W4313308107 cites W3107284527 @default.
• W4313308107 cites W3113271342 @default.
• W4313308107 cites W3140226555 @default.
• W4313308107 cites W3142488412 @default.
• W4313308107 cites W3163593731 @default.
• W4313308107 cites W3175779801 @default.
• W4313308107 cites W3185635616 @default.
• W4313308107 cites W3186749653 @default.
• W4313308107 cites W3200879206 @default.
• W4313308107 cites W3203067111 @default.
• W4313308107 cites W4206715449 @default.
• W4313308107 cites W4210392855 @default.
• W4313308107 cites W4210511145 @default.
• W4313308107 cites W4210755204 @default.
• W4313308107 cites W4220658981 @default.
• W4313308107 cites W4223448922 @default.
• W4313308107 cites W4226341999 @default.
• W4313308107 cites W4226514831 @default.
• W4313308107 cites W4304756671 @default.
• W4313308107 doi "https://doi.org/10.1371/journal.pone.0279333" @default.
• W4313308107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36583998" @default.
• W4313308107 hasPublicationYear "2022" @default.
• W4313308107 type Work @default.
• W4313308107 citedByCount "9" @default.
• W4313308107 countsByYear W43133081072023 @default.
• W4313308107 crossrefType "journal-article" @default.
• W4313308107 hasAuthorship W4313308107A5002630544 @default.
• W4313308107 hasAuthorship W4313308107A5003926280 @default.
• W4313308107 hasAuthorship W4313308107A5009775466 @default.
• W4313308107 hasAuthorship W4313308107A5011188783 @default.
• W4313308107 hasAuthorship W4313308107A5012837780 @default.
• W4313308107 hasAuthorship W4313308107A5016245888 @default.
• W4313308107 hasAuthorship W4313308107A5023337969 @default.
• W4313308107 hasAuthorship W4313308107A5033100094 @default.
• W4313308107 hasAuthorship W4313308107A5040418600 @default.
• W4313308107 hasAuthorship W4313308107A5043877348 @default.
• W4313308107 hasAuthorship W4313308107A5044111360 @default.
• W4313308107 hasAuthorship W4313308107A5045809081 @default.
• W4313308107 hasAuthorship W4313308107A5046413590 @default.
• W4313308107 hasAuthorship W4313308107A5046485954 @default.
• W4313308107 hasAuthorship W4313308107A5058854673 @default.
• W4313308107 hasAuthorship W4313308107A5059280833 @default.
• W4313308107 hasAuthorship W4313308107A5073613740 @default.
• W4313308107 hasAuthorship W4313308107A5075033637 @default.
• W4313308107 hasAuthorship W4313308107A5078376667 @default.
• W4313308107 hasAuthorship W4313308107A5079151837 @default.
• W4313308107 hasAuthorship W4313308107A5079240490 @default.
• W4313308107 hasAuthorship W4313308107A5081547954 @default.
• W4313308107 hasAuthorship W4313308107A5081887838 @default.
• W4313308107 hasAuthorship W4313308107A5089766701 @default.
• W4313308107 hasBestOaLocation W43133081071 @default.
• W4313308107 hasConcept C126322002 @default.
• W4313308107 hasConcept C167135981 @default.
• W4313308107 hasConcept C201903717 @default.
• W4313308107 hasConcept C203092338 @default.
• W4313308107 hasConcept C207103383 @default.
• W4313308107 hasConcept C2779134260 @default.
• W4313308107 hasConcept C3008058167 @default.
• W4313308107 hasConcept C44249647 @default.
• W4313308107 hasConcept C50382708 @default.

• next